Screening Pregnant and Postpartum Women for Substance Use Disorder. MPQC Fall Summit November 14, 2018

Size: px
Start display at page:

Download "Screening Pregnant and Postpartum Women for Substance Use Disorder. MPQC Fall Summit November 14, 2018"

Transcription

1 Screening Pregnant and Postpartum Women for Substance Use Disorder MPQC Fall Summit November 14, 2018

2 Disclosures No relevant financial or non-financial relafonships

3 Screening Pregnant and Postpartum Women for Substance Use Disorder Screening vs. TesFng Screening for Substance Use Disorder (SUD) as Part of RouFne Prenatal Care Fentanyl: a Local Update

4 AddicFon is a Disease AddicFon is TREATABLE

5 Screening for SUD in Pregnancy

6 Substance Use in Pregnancy 5% pregnant women use illicit substances 10% drink alcohol 15% use tobacco More common than: GDM (6-8%) Preeclampsia (5%) WrightT et al The role of screen, brief intervenfon and referral to treatment in the perinatal period AJOG Nov 2016

7 Worcester Area: Substance Use in Pregnancy 5% pregnant women use illicit substances 10% drink alcohol 15% use tobacco 9.8% use illicit substances 0.9% drink alcohol 14.3% use tobacco 112 New Ob PaFents in CWC Jan 2017 April 2017 Denied Tobacco EtOH "Drugs"

8 How should do we screen? Screening for substance abuse is a part of complete obstetric care and should be done in partnership with the pregnant woman Rou%ne screening should rely on validated screening tools ACOG CO Number 711, August 2017 (Replaces Commi.ee Opinion Number 524, May 2012)

9 Isn t informal screening good enough? Do we all ask the same way? Relying on self-report underesfmates the frequency and severity of use in pregnant women 40-60% of cases missed when later compared to objecfve laboratory results Garg M, Garrison L, Leeman L, Hamidovic A, Borrego M, Rayburn WF, Bakhireva L. Validity of Self-Reported Drug Use InformaFon Among Pregnant Women. Matern Child Health J Jan;20(1):41-7

10 Isn t informal screening good enough? 127 new pafents over 6 mos period 117 were asked about SUD at IOB 27 were screened for SUD using a standard tool 7 of the 27 (25.9%) screened posifve for substance use 1 pafent screened posifve and was not asked at first visit 3 of the 6 pafents (50%) screened in by the NIDA Quick Screen denied substance use during the informal screen.

11 Screening for SUD IntervenFon: moving screen from nursing intake to first Ob visit, training residents in SBIRT Pre Post % screened by NIDA 19.3% 63.4% % of NIDA screening posifve 25.9% 36.2% % screened by informal means 90% 88.2% % informal screening posifve 21.4% 17.3%

12 Universal Screening SUD occurs in every socioeconomic class, and racial and ethnic group Recommended by: ACOG - AMA AAP - CDC Screen at the first prenatal visit (at least) ACOG CO Number 711, August 2017 WrightT et al The role of screen, brief intervenfon and referral to treatment in the perinatal period AJOG Nov 2016

13 Why not Universal TESTING? False posifves are a real thing ParFcularly immunoassays Long-term maternal effects: Medical Legal Familial Substance Abuse and Mental Health Services AdministraFon, PrevenFon of substance abuse and mental illness SAMHSA.gov/prevenFon

14 Biological Samples: Screening vs Urine Drug Screen aka Immunoassays Rapid, Cheap, Automated Results as posifve or negafve Can be POCT High rate of false posifves PosiFves should be followed with confirmatory tesfng TesFng GMahajan Role of Urine Drug TesFng in the Current Opioid Epidemic Anesthesia and Analgesia December 2017 Volume 125 Number 6

15 UDS - Immunoassays: Common False PosiFves Substance Amphetamines Benzodiazepines Buprenorphine Methadone Opiates Buproprion Chlorpromazine FluoxiFne Labetolol Menormin Efavirenz Sertraline Codeine Morphine Methadone Tramadol Diphenhydramine QueFapine Verapamil Dextromethorphone Diphenhydramine Fluoroquinalones Poppy seeds Possible cross-reac%ng drugs Ofloxacin Promethazine Pseudoephedrine Trazadone Quinine Rifampin Verapamil MahajanG (2017). Role of Urine Drug tesfng in the Current Opioid Epidemic. Anesthesia & Analgesia. December 2017 Volume 125 Number 6 p SaitmanA, ParkHD, FitzgeraldR (2014). False-PosiFve Interferences of Common Urine Drug Screen Immunoassays: A Review. Journal of AnalyFcal Toxicology, Volume 38, Issue 7, 1 September 2014, p

16 UDT Confirmatory Urine Drug Tests Gas or liquid chromatography mass spectrometry Cost of tesfng related to number of substances tested $250-$1400 SFll has risk of false posifve or false negafve results Can enhance pafent care Confirm compliance Detect non-compliance Inform use MahajanG (2017). Role of Urine Drug tesfng in the Current Opioid Epidemic. Anesthesia & Analgesia. December 2017 Volume 125 Number 6 p SaitmanA, ParkHD, FitzgeraldR (2014).

17 UDT Confirmatory Urine Drug Tests Drug Toxicology Monitoring 1 with Confirma%on, Urine Amphetamines, Benzodiazepines, Buprenorphine, Cocaine Metabolite, Heroin Metabolite, Marijuana Metabolite 20, Methadone Metabolite, Opiates, Oxycodone Drug Toxicology Monitoring 2 with Confirma%on, Urine Amphetamines, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine Metabolite, Heroin Metabolite, Marijuana Metabolite 20, Methadone Metabolite, Opiates, Oxycodone Drug Toxicology Monitoring 6 with Confirma%on, Urine Amphetamines, Barbiturates, Benzodiazepines, Cocaine Metabolite, Marijuana Metabolite 20, Methadone Metabolite, Opiates, Oxycodone, Phencyclidine Drug Toxicology Monitoring 9 with Confirma%on, Urine Amphetamines, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine Metabolite, Heroin Metabolite, Marijuana Metabolite 20, MDMA/MDA, Methadone Metabolite, Opiates, Oxycodone, Phencyclidine MahajanG (2017). Role of Urine Drug tesfng in the Current Opioid Epidemic. Anesthesia & Analgesia. December 2017 Volume 125 Number 6 p SaitmanA, ParkHD, FitzgeraldR (2014).

18 Screening Tools NIDA Quick Screen 4Ps TWEAK CRAFFT ACOG CO Number 711, August 2017 WrightT et al The role of screen, brief intervenfon and referral to treatment in the perinatal period AJOG Nov 2016

19 Screening Tools NIDA Quick Screen 4Ps Parents, Partner, Past, Pregnancy TWEAK CRAFFT ACOG CO Number 711, August 2017

20 Screening Tools NIDA Quick Screen 4Ps Parents, Partner, Past, Present / Pregnancy TWEAK CRAFFT 1. Have you ever used drugs or alcohol during Pregnancy? 2. Have you had a problem with drugs or alcohol in the Past? 3. Does your Partner have a problem with drugs or alcohol? 4. Do you consider one of your Parents to be an addict or alcoholic? HEwing A PracFcal Guide to IntervenFon in Health and Social Services with Pregnanct and Postpartum Addicts and Alcoholics: theorefcal framework, brief screening tool, key interview quesfons, and strategies for recovery resources Born Free Project, Contra Costa County DPH

21 Screening Tools NIDA Quick Screen 4Ps TWEAK Developed for alcohol use in pregnancy CRAFFT T Tolerance How many drinks can you hold? W Worried Have close friends or relafves worried or complained about your drinking in the past year? E Eye-opener Do you somefmes take a drink in the morning when you first get up? A Amnesia stands for blackouts Has a friend or family member ever told you about things you said or did while you were drinking that you could not remember? K K/Cut Down Do you somefmes feel the need to cut down on your drinking? ACOG CO Number 711, August 2017 WrightT et al The role of screen, brief intervenfon and referral to treatment in the perinatal period AJOG Nov 2016

22 Screening Tools NIDA Quick Screen 4Ps TWEAK CRAFFT Developed for adolescents Car, Relax, Alone, Forget, Family/Friends, Trouble ACOG CO Number 711, August 2017

23 So I screened now what? Screening Brief Interven%on Referral to Treatment Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G6 Creanga AA. The role of screening, brief intervenfon, and referral to treatment in the perinatal period. Am J Obstet Gynecol Nov;215(5):

24 So I screened now what? Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G6 Creanga AA. The role of screening, brief intervenfon, and referral to treatment in the perinatal period. Am J Obstet Gynecol Nov;215(5):

25 OUD in Worcester

26 OUD in Worcester 2017: Statewide trend of decreasing numbers of death by opioid overdose Statewide, deaths from overdose down 8.2% Increase in awareness, Narcan prescribing

27 OUD in Worcester 2017: Statewide trend of decreasing numbers of death by opioid overdose Worcester County deaths confnue to increase Opioid Related Deaths

28 OUD in Worcester 2017: Statewide trend of decreasing numbers of death by opioid overdose Worcester County deaths confnue to increase May be due to increasing amounts of Fentanyl MA OD Deaths 2017 Fentanyl Non-Fentanyl

29 OUD in Worcester 2017: Statewide trend of decreasing numbers of death by opioid overdose Worcester County deaths confnue to increase May be due to increasing amounts of Fentanyl MA OD Deaths 2017 UMASS Non-fatal ODs 2017 Fentanyl Non-Fentanyl Fentanyl Non-Fentanyl

30 OUD in Worcester 2017: Statewide trend of decreasing numbers of death by opioid overdose Worcester County deaths confnue to increase May be due to increasing amounts of Fentanyl

31 Street opioid trade in Worcester dominated by fentanyl Heroin now used to cut fentanyl Reports of carfentanil BSAS June 2018 advisory: Fentanyl + cocaine in 43% of ODs BSAS June 2016 advisory: Fentanyl + cocaine pressed to look like Perc 30s. OUD in Worcester DRUG ENFORCEMENT ADMIN Dea.gov

32 OUD in Worcester Green Clinic Urine Tox - Sept 2018: 10/42 Urine Tox PosiFve Sept /10 posi%ve, posi%ve for fentanyl 2/10 posifve, posifve for heroin metabolite Urine Toxicologies in Green Clinic September 2018 Neg Pos Fentanyl Other

33 OUD in Worcester Opioid related deaths confnue to increase in Worcester Street level opioid now dominated by FENTANYL Majority of high-risk populafon tests posifve for FENTANYL and not other opioids FENTANYL *MAY NOT* BE INCLUDED IN URINE DRUG TEST PANELS

34 In Conclusion Please Screen for SUD with a Standardized Tool Know your tests FENTANYL is on the rise THANK YOU!

PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN

PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN 1 OPIOID USE DISORDER IN WOMEN Recognition & Prevention Date: August 14 th, Time: 8 am Presenters: Deepa Nagar MD, Andria Peterson PharmD Maternal Treatment

More information

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing Mississippi Primary Health Care Association Pearl, MS March 7, 2018 Scott Hambleton, MD, DFASAM Medical

More information

ADDICTION IN PREGNANCY

ADDICTION IN PREGNANCY ADDICTION IN PREGNANCY R. Corey Waller MD, MS, DFASAM Sr. Medical Director, Education and Policy The National Center for Complex Health and Social Needs DISCLOSURES No relevant disclosures OBJECTIVES The

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine Opioid Use Disorders and Pregnancy Marcela Smid, MD Maternal-Fetal Medicine UNIVERSITY OF UTAH HEALTH, 2017 OBJECTIVES Definitions Epidemiology Pharmacology Effects on pregnancy Screening Treatment CARE

More information

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA THE OPIOID CRISIS DEFINING THE CRISIS KATHLEEN DUPPER, MD MEDICAL DIRECTOR, HUNTSVILLE RECOVERY 19 th Annual Perinatal Conference: The Opioid Crisis September 21, 2018 DEFINING THE CRISIS NUMBER OF OPIOID-RELATED

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

URINE DRUG TOXICOLOGY

URINE DRUG TOXICOLOGY Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences URINE DRUG TOXICOLOGY Suzanne E. Rapp, MD GENERAL DISCLOSURES The University of Washington School of Medicine also

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016 Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of

More information

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

Urine Drug Testing (UDT) in Pain Management. Nov 27, 2017

Urine Drug Testing (UDT) in Pain Management. Nov 27, 2017 Urine Drug Testing (UDT) in Pain Management Nov 27, 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or

More information

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences 12/13/2018 WELCOME! Today s Topic: Urine Drug Screens in OUD Treatment Should I test and how should I do drug testing

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements found in the opium poppy plant. These drugs are

More information

Urine Drug Testing (UDT) to Monitor Opioid Use. Feb 2018

Urine Drug Testing (UDT) to Monitor Opioid Use. Feb 2018 Urine Drug Testing (UDT) to Monitor Opioid Use Feb 2018 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or

More information

COUNTY OF SAN DIEGO. Opioid Update

COUNTY OF SAN DIEGO. Opioid Update COUNTY OF SAN DIEGO Opioid Update Linda Bridgeman Smith, DUI & Prevention Services Manager Health & Human Services Agency, Behavioral Health Services Co-chair, Prescription Drug Abuse Task Force 1 HEADLINES

More information

Does ultram show up as an opiate

Does ultram show up as an opiate Search Does ultram show up as an opiate Tramadol ( Ultram ) is prescribed for treating moderate to severe pain in adults. 19-2-2018 I took Tramadol Hydrochloride for 6 months due to joint pain from my

More information

Urine Drug Testing (UDT) in Pain Management. Nov 5, 2017

Urine Drug Testing (UDT) in Pain Management. Nov 5, 2017 Urine Drug Testing (UDT) in Pain Management Nov 5, 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or

More information

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent? Objectives Drug Testing Interpretation in Addiction Care Brandi Puet, Pharm.D. Describe the difference between immunoassay and confirmatory testing. List explanations for unexpected negative or positive

More information

Cutoff levels for hydrocodone in a blood test

Cutoff levels for hydrocodone in a blood test Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.

More information

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty

More information

Disclosures. Get Your Specimens in Order:

Disclosures. Get Your Specimens in Order: Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Jennifer Bolen, JD Disclosures Jennifer Bolen, JD Consultant to Generation Partners Consultant to Abbott

More information

Testing for Controlled Substances

Testing for Controlled Substances Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Patient Rx Drug Misuse and Abuse: Compliance Toxicology Monitoring in Clinical Practice Toxicology Staff Andrea Terrell, Ph.D., DABCC Chief Scientific Officer George Behonick, Ph.D., DABFT, Manager, FBU

More information

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management Urine Drug Testing in Chronic Pain Management March 8, 2018 Faculty/Presenter Disclosure Faculty: Andrew J Smith, MDCM Relationships with commercial interests: None to report Andrew J Smith, MDCM Staff

More information

Methadone and Pregnancy

Methadone and Pregnancy Methadone and Pregnancy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Charissa Patricelli, MD, CCFP, ABAM Clinical Associate Professor, Dept. of Family Practice UBC American Board of Addiction Medicine

More information

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Opioids in Pregnancy. Beyond to Baby GENERAL INFO Opioids in Pregnancy and Beyond to Baby by Marcia W. VanVleet, MD, MPH Medical Director, Newborn Service Team, Women and Infants Hospital, and Assistant Professor of Pediatrics, Brown Alpert Medical School,

More information

Overview. Opioids and HIV Infection: From Pain Management to Addiction Treatment

Overview. Opioids and HIV Infection: From Pain Management to Addiction Treatment FORMATTED: 01/23/2017 New York, New York: February 24, 2017 Opioids and HIV Infection: From Pain Management to Addiction Treatment Chinazo Cunningham, MD, MS Professor of Medicine Albert Einstein College

More information

Torri Metz, MD Maternal-Fetal Medicine December 15, 2017

Torri Metz, MD Maternal-Fetal Medicine December 15, 2017 Torri Metz, MD Maternal-Fetal Medicine December 15, 2017 I have no relevant financial relationships to disclose or conflicts of interest to resolve. Describe public health impact of expanding marijuana

More information

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch

More information

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine? Gold Standard for Urine Drug Testing Developed by TRMC Pain Management Center Jill Duffy, RN,BC Pam Kennell, RN, BC Heidi Beisch, RN Urine Drug Testing A DIAGNOSTIC tool For an OBJECTIVE test Based on

More information

Drug Screening: Things You Need to Know

Drug Screening: Things You Need to Know Drug Screening: Things You Need to Know (a view inside the clinical laboratory) Gary L. Horowitz, MD Director, Clinical Chemistry, Beth Israel Deaconess Medical Center Associate Professor of Pathology,

More information

benzodiazepine Wellbutrin false positive benzodiazepine

benzodiazepine Wellbutrin false positive benzodiazepine Wellbutrin false positive benzodiazepine The Borg System is 100 % Wellbutrin false positive benzodiazepine 26-5-2016 Find out which drugs can potentially cause a false positive drug test including additional

More information

Opioid Use in Youth. Amy Yule M.D. March 2,

Opioid Use in Youth. Amy Yule M.D. March 2, Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin

More information

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a

More information

Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids

Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Background The American Society of Addiction Medicine (ASAM) is deeply committed

More information

Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need

Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need 18-8-2017 Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need to pass the test 2-2-2018 25 Answers (question resolved)

More information

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples

More information

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities 10/26/15 Perspec'ves on maternal opioid use and abuse Dr. Rita J. Nutt Our Expectation Harsh Realities 1 Opioid Abuse and Dependence Statistics, 2013 4.5 million people in the US current non- medical users

More information

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment This webinar will be recorded and available on the NPIC/QAS website www.npic.org. Nurse Planner:

More information

Urine drug testing it s not always crystal clear

Urine drug testing it s not always crystal clear Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine

More information

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Prepared by: Robert G. Carlson, Ph.D., Professor and Director, Project Director Linna Li, M.S., Data Manager Raminta Daniulaityte,

More information

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50 Clinical Policy: Reference Number: PA.CP.MP.50 Effective Date: 01/18 Last Review Date: 09/17 Coding Implications Revision Log Description Urine drug testing is a key diagnostic and therapeutic tool that

More information

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Dale Robinson MD,FACOG Jennifer Gonzalez RN,BSN Surgeon General s Report 2016 Office

More information

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM Patient-Centered Urine Drug Testing Douglas Gourlay, MD, MSc, FRCPC, FASAM Declaration of Potential Conflict of Interest The content of this presentation is non- commercial and does not represent any conflict

More information

Pain Management Drug Testing: A Laboratory Perspective

Pain Management Drug Testing: A Laboratory Perspective Ernest Jimenez III, M.T.(ASCP) Nothing to declare. Laboratory manager at Pharos Diagnostics, LLC., located in Tucson, AZ. Pain Management Drug Testing: A Laboratory Perspective 1 2 Pain Management Drug

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

TOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM

TOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM TOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM Using Locally Available Data Richard Harruff, MD, PhD Chief Medical Examiner Julia Hood, PhD, MPH Epidemiologist Goals for Today s Presentation 1. Make

More information

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Opioid Prescription and Illicit Drug Overdoses: On the Rise Opioid Prescription and Illicit Drug Overdoses: On the Rise Cindy Haynes, MSA-PA, CHES Chronic Pain Program Coordinator Northern Piedmont Community Care Duke Division of Community Health Objectives Define

More information

Training physicians who care for adolescents and young adults. Richard Blondell MD ABAM-Foundation. with support from The Conrad N.

Training physicians who care for adolescents and young adults. Richard Blondell MD ABAM-Foundation. with support from The Conrad N. Training physicians who care for adolescents and young adults Richard Blondell MD ABAM-Foundation with support from The Conrad N. Hilton Foundation A request for a presentation for the pediatric grand

More information

The Utility of Urine Drug Screening

The Utility of Urine Drug Screening The Utility of Urine Drug Screening Treating Addiction, Saving Lives Sea Cruises Bye Tazmania, still far from New Zealand February 8 th, 2018 Mandy Manak, MD FASAM, ISAM, CSAM, MRO Medical Director, ICDO

More information

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE

More information

Addressing the Opioid Crisis Policy Recommendations

Addressing the Opioid Crisis Policy Recommendations Addressing the Opioid Crisis Policy Recommendations The Pew Charitable Trusts Pew is an independent nonprofit, nonpartisan research and policy organization. Tools: Research Partnerships Technical assistance

More information

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Gwen McMillin, PhD, DABCC(CC,TC) Professor, University of Utah Medical Director,

More information

Aetna s Initiative on the Opioid Epidemic

Aetna s Initiative on the Opioid Epidemic Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than

More information

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING Opioid Use Disorder in Pregnancy 2017 Recommendations from ACOG and The Pew Charitable Trust KATHY D. HARTKE, MD, LEGISLATIVE CO-CHAIR AND IMMEDIATE PAST CHAIR, WISCONSIN SECTION OF THE AMERICAN COLLEGE

More information

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome Meghan Howell, MD FAAP Assistant Professor of Pediatrics Clinical Director, Tulane NICU Graduate Clinic Tulane University School

More information

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Opioid use in pregnancy and Neonatal Abstinence Syndrome Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,

More information

Montgomery County Poisoning Death Review

Montgomery County Poisoning Death Review Wright State University CORE Scholar Unintentional Prescription Drug Poisoning Project Center for Interventions, Treatment and Addictions Research Montgomery County Poisoning Death Review - Center for

More information

Prescribing Opioid for. Opioid Naïve Patients AN OPIOD RX

Prescribing Opioid for. Opioid Naïve Patients AN OPIOD RX Prescribing Opioid for Opioid Naïve Patients AN OPIOD RX Optimal Approach to Initiating Opioids for Chronic Non-Cancer Pain AN OPIOID RX Assessment biopsychosocial Non-opioid treatments Opioid risks vs.

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Does tramadol test positive

Does tramadol test positive P ford residence southampton, ny Does tramadol test positive Jul 19, 2017. Salvia Tests. With saliva testing, a saliva sample is taken from the mouth of an individual and then screened for tramadol and

More information

Prescription Opioids

Prescription Opioids What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made

More information

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE Valerie Carrejo, MD Assistant Professor UNM Family Medicine Advances in Primary Care April 14, 2017 Objectives Review the basic

More information

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management bs_bs_banner Pain Medicine 2013; 14: 1813 1820 Wiley Periodicals, Inc. PROFESSIONALISM AND COMMENTARY Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management Disclosure: The

More information

Effects of Prenatal Illicit Drug. Use on Infant and Child

Effects of Prenatal Illicit Drug. Use on Infant and Child Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this

More information

Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China

Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China The Opioid Epidemic In Broward County 8/24/217 Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY Jim Hall Senior Epidemiologist Center for Applied Research on Substance

More information

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective Article in press - uncorrected proof Clin Chem Lab Med 2009;47(8):971 976 2009 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2009.220 2009/180 Analysis and interpretation of drug testing results

More information

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G

More information

Pain Medication Management Program Supports Patient Outcomes and Adherence

Pain Medication Management Program Supports Patient Outcomes and Adherence PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety

More information

Flexeril positive for benzos

Flexeril positive for benzos Flexeril positive for benzos Search 29-5-2014 Question - Does flexeril show up in drugtests tests,freedom again.i know flexeril is not a benzodiazepine that gave me the positive result for Benzos. include

More information

Pain Medication Management Program Monitors Patient Compliance

Pain Medication Management Program Monitors Patient Compliance PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

More information

Substance Use Disorders in Pregnant Women: Approach to the Management in Prenatal, Perinatal, and Postnatal Periods

Substance Use Disorders in Pregnant Women: Approach to the Management in Prenatal, Perinatal, and Postnatal Periods Substance Use Disorders in Pregnant Women: Approach to the Management in Prenatal, Perinatal, and Postnatal Periods Cresta Jones, MD Charles Schauberger, MD Conflict of Interests Drs Schauberger and Jones

More information

Powering Efficient Behavioral Health Care Services

Powering Efficient Behavioral Health Care Services Powering Efficient Behavioral Health Care Services Streamlining behavioral health care decisions through comprehensive and efficient drug monitoring Quest Diagnostics has you and your patients covered

More information

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response Reducing Opioid Deaths: Arizona s Emergency Declaration & Response September 15, 2017 Sheila Sjolander, Assistant Director Arizona Department of Health Services Emergency Declaration On June 5, 2017, Arizona

More information

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC:

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: Cuyahoga County Board of Health OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: NOVEMBER 5, 2014 CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements

More information

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Buprenorphine Initiation and Maintenance in Pregnancy (Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Assessment The diagnosis of OUD should be confirmed by DSM-5

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis

REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN Lyn Raible, M.D., Ph.D. CMO, Aegis ORGANIZATION The Opioid Crisis Breaking the Stigma Neurobiology of Opioid Addiction Treatment of Opioid

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

Wednesday, April, 18, :00 p.m. Eastern

Wednesday, April, 18, :00 p.m. Eastern Wednesday, April, 18, 2018 2:00 p.m. Eastern Dial In: 888.863.0985 Conference ID: 49390420 Slide 1 Speakers Daisy Goodman, DNP, CNM, MPH Department of Obstetrics and Gynecology Moms in Recovery Program

More information

Opioid Epidemic as it Relates to Counties

Opioid Epidemic as it Relates to Counties 89 TH ANNUAL WEST TEXAS COUNTY JUDGES AND COMMISSIONERS ASSOCIATION CONFERENCE Wednesday, April 25, 2018 11:05 11:55 a.m. Opioid Epidemic as it Relates to Counties Ms. Jessica Cance Agency Analytics Unit

More information

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem Objectives Discuss the recent spread of opioid misuse Discuss the rise of the current opioid crisis, a national addiction/overdose problem Includes medical and illicit opioids Objectives Discuss the dangers

More information

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction

More information

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217

More information

Developing a Clinical Pathway to Improve School-Based Health Care for Adolescent Substance Abuse. Winona Stoltzfus, MD

Developing a Clinical Pathway to Improve School-Based Health Care for Adolescent Substance Abuse. Winona Stoltzfus, MD Developing a Clinical Pathway to Improve School-Based Health Care for Adolescent Substance Abuse Winona Stoltzfus, MD 1 Acknowledgments Mary M. Ramos, MD, MPH Envision New Mexico Terri Chauvet & McKane

More information

Changing Course: statewide efforts to combat the opioid epidemic in California

Changing Course: statewide efforts to combat the opioid epidemic in California Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries

More information

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Physician s Reference for Urine and Blood Drug Testing and Interpretation Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine

More information

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Scott M. Gagnon, MPP, PS-C Director, AdCare Educational Institute of Maine, Inc. Co-Chair, Prevention & Harm

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008 INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 28 A report from the Office of Epidemiology and Planning Baltimore City Health Department

More information

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower. The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call

More information

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017 Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug

More information

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE

More information

Addressing the Opioid Epidemic in Tennessee

Addressing the Opioid Epidemic in Tennessee Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for

More information

The Role of Opioid Overdoses in Confirmed Maternal Deaths,

The Role of Opioid Overdoses in Confirmed Maternal Deaths, The Role of Opioid Overdoses in Confirmed Maternal Deaths, 2012-2015 Introduction The Department of State Health Services (DSHS) conducted an analysis of maternal deaths resulting from drug overdoses from

More information